22.02.2024 - Strong commercial performance of IBSRELA continues, ending FY 2023 with $80.1 million in net product sales revenue; 2024 net product sales revenue currently expected to be between $140.0 to $150.0 million XPHOZAH launch off to a strong start, .
Strong commercial performance of IBSRELA continues, ending FY 2023 with $80.1 million in net product sales revenue; 2024 net product sales revenue currently expected to be between $140.0 to $150.0
Revenue $85.3 million in Q4 2023 $310.8 million in FY 2023 Profit $3.2 million in Q4 2023 $13.8 million in FY 2023 Adjusted EBITDA, a Non-IFRS measure.
Garrett Motion Inc : Garrett Motion Delivers Strong 2023, Issues 2024 Outlook, Authorizes New $350M Share Repurchase Program finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Fourth Quarter 2023 Highlights Net sales totaled $945 million, up 5% on a reported basis, up 3% at constant currency Net income totaled $52 million; Net income margin 5.5%Adjusted EBITDA totaled.